论文部分内容阅读
把两种不同的人体细胞使之结合并繁衍,能产生一种物质用来治疗癌瘤和其它的疾病,这是当前医学发展的一项新技术。实验证明,细胞结合后是可以产生数量丰富、靶子针对性强的特种纯抗体。这种技术最重要的一环是探寻如何产生人体肿瘤的抗体,这种抗体和放疗或化疗一样,能使癌细胞破坏和中止生长,但对周围正常组织则影响不大,亦没有一般抗癌药物引起的呕吐、脱发等不良反应。此外,用放射核素标记的肿瘤抗体来示踪,了解癌
Combining and multiplying two different types of human cells can produce a substance that can be used to treat cancers and other diseases. This is a new technology in current medical development. Experiments have shown that after the cells are bound, they can produce a large number of unique and highly targeted antibodies. The most important aspect of this technology is to find out how to produce antibodies to human tumors. Like the radiotherapy or chemotherapy, this kind of antibodies can destroy and stop the growth of cancer cells, but it has little effect on surrounding normal tissues and there is no general anti-cancer effect. Drug-induced vomiting, hair loss and other adverse reactions. In addition, radionuclide-labeled tumor antibodies are used to track cancer.